Ausgewählte Studien

BOSTON — New Endocrine Society guidelines call for limiting vitamin D supplementation beyond the daily recommended intake to specific risk groups and …Den ganzen Artikel lesen

Commentary on ‘perceived stress in four inflammatory skin diseases: An analysis of data taken from 7273 adult subjects with acne, psoriasis, atopic …Den ganzen Artikel lesen

Actas Dermosifiliogr. 2022 Jun 9:S0001-7310(22)00477-X. doi: 10.1016/j.ad.2022.06.003. Online ahead of print. ABSTRACT OBJECTIVE: To analyse the rate of implementation of the Psoriasis Group (GPS) recommendations for the management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding. METHODS: A closed, structured, anonymous survey was designed and sent in electronic format to GPS members via email. Sociodemographic and professional variables were collected, as well as oth

Actas Dermosifiliogr. 2024 Mar 11:S0001-7310(24)00201-1. doi: 10.1016/j.ad.2024.03.013. Online ahead of print. ABSTRACT BACKGROUND: Generalized pustular psoriasis (GPP) is a rare and severe inflammatory skin disease characterised by recurrent or intermittent flares. Epidemiological and disease management data in Spain are limited. Our goal was to estimate the epidemiology of GPP, explore its management, and reach consensus on the current challenges faced in Spain. METHODS: An electronic survey w

Actas Dermosifiliogr. 2024 Feb 5:S0001-7310(24)00082-6. doi: 10.1016/j.ad.2023.07.028. Online ahead of print. ABSTRACT BACKGROUND: The past 5 years have seen a proliferation of new treatments for atopic dermatitis (AD). We analyzed recent drug survival data for cyclosporine in this setting. Because the Spanish National Healthcare system requires patients with AD to be treated with cyclosporine before they can be prescribed other systemic treatments, drug survival for cyclosporine may be shorter

Actas Dermosifiliogr. 2023 Oct 31:S0001-7310(23)00850-5. doi: 10.1016/j.ad.2023.10.019. Online ahead of print. ABSTRACT Psoriasis and hidradenitis suppurativa are often associated with obesity. Because chronic low-grade inflammation underlies these 2 diseases, they can progress to more severe forms in patients with obesity if weight-reduction measures are not taken. This review covers pharmacologic alternatives for treating obesity, with emphasis on the benefits associated with the novel use of

Actas Dermosifiliogr. 2024 Jan 17:S0001-7310(24)00035-8. doi: 10.1016/j.ad.2024.01.019. Online ahead of print. ABSTRACT BACKGROUND AND OBJECTIVE: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescr

Background: Chronic inflammatory diseases (immune-mediated inflammatory diseases, IMID) can overlap or occur simultaneously due to clinical …Den ganzen Artikel lesen

Background: Immune-mediated inflammatory diseases (IMID) can lead to a substantial disease burden for those affected, in particular by the …Den ganzen Artikel lesen

Actas Dermosifiliogr. 2023 Apr 15:S0001-7310(23)00292-2. doi: 10.1016/j.ad.2023.04.013. Online ahead of print. ABSTRACT Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially impor

Actas Dermosifiliogr. 2022 Mar 7:S0001-7310(22)00207-1. doi: 10.1016/j.ad.2021.05.027. Online ahead of print. ABSTRACT Childhood-onset psoriasis generally follows an indolent course but patients with moderate or severe disease may require systemic treatment. The aim of this study was to determine the relative proportion of children and young people aged up to 21 years with moderate to severe psoriasis in the BIOBADADERM registry and to analyze the characteristics of these patients, treatments us

Actas Dermosifiliogr. 2022 Jun;113(6):T583-T609. doi: 10.1016/j.ad.2022.01.040. Epub 2022 May 21. ABSTRACT BACKGROUND AND OBJECTIVES: Since its inception, the Psoriasis Group (GPs) of the Spanish Academy of Dermatology and Venereology (AEDV) has worked to continuously update recommendations for the treatment of psoriasis based on the best available evidence and incorporating proposals arising from and aimed at clinical practice. An updated GPs consensus document on the treatment of moderate to s

Actas Dermosifiliogr. 2022 Feb 8:S0001-7310(22)00141-7. doi: 10.1016/j.ad.2021.10.011. Online ahead of print. ABSTRACT BACKGROUND AND OBJECTIVES: A new, updated AEDV Psoriasis Group (GPs) consensus document on the treatment of moderate to severe psoriasis was needed owing to the approval, in recent years, of a large number of new drugs and changes in the treatment paradigm. METHODOLOGY: The consensus document was developed using the nominal group technique and a scoping review. First, a designat

Actas Dermosifiliogr. 2023 May 10:S0001-7310(23)00346-0. doi: 10.1016/j.ad.2023.02.022. Online ahead of print. ABSTRACT The advent of biosimilar drugs and their use in routine clinical practice has revolutionized the management of moderate to severe psoriasis and led to changes in the positioning of the existing molecules used to control this condition. Evidence from clinical trials complemented by real-world experience has helped to clarify concepts and has significantly changed the use and pos

Appl Health Econ Health Policy. 2023 May 30. doi: 10.1007/s40258-023-00815-7. Online ahead of print. ABSTRACT OBJECTIVES: The German Pharmaceutical Market Restructuring Act (AMNOG, 2011) is a two-stage process to regulate the price of new pharmaceuticals in which price negotiations are conducted based on evidence-based medical benefit assessments using data from prior clinical trials. Although the act does not explicitly set a willingness-to-pay (WTP) threshold, the process itself implicitly est

Dermatologie (Heidelb). 2024 Jan 2. doi: 10.1007/s00105-023-05288-2. Online ahead of print. NO ABSTRACT PMID:38167779 | DOI:10.1007/s00105-023-05288-2 Den ganzen Artikel lesen

Den ganzen Artikel lesen

Den ganzen Artikel lesen

Original Paper Background: A teledermoscopy service was established in January 2010 wherein patients attended nurse-led clinics for the imaging of …Den ganzen Artikel lesen

Acta Derm Venereol. 2023 Apr 4;103:adv3962. doi: 10.2340/actadv.v103.3962. ABSTRACT The impact of dermatological diseases goes beyond symptoms and often includes psychosocial burden. Self-stigmatization plays a key role in this relationship and was compared in patients with psoriasis and atopic dermatitis to evaluate the validity of cross-disease stigmatization models. In total, 101 patients per indication were included in this cross-sectional study. Besides sociodemographic and clinical data, p

LETTER TO THE EDITOR A Cross-sectional Comparison of Eczema and Psoriasis Patients with Regards to Cardiovascular Disease and Risk Factors N. …Den ganzen Artikel lesen

JMIR Form Res. 2022 Jul 7;6(7):e32593. doi: 10.2196/32593. ABSTRACT BACKGROUND: Psoriasis is a chronic disease characterized by inflammation, increased scaling, itching, and other symptoms. Psoriasis is not contagious, but patients have often felt shunned. Therefore, in addition to psoriasis symptoms, stress, anxiety, and depression can also affect quality of life (QoL). Surveys show that only a quarter of patients are satisfied with the success of their therapy. However, in addition to medical

Full text linksCite Display options Display options Immune-mediated inflammatory diseases (IMIDs) constitute a heterogenous group of chronic and highly …Den ganzen Artikel lesen

Life (Basel). 2021 Jun 29;11(7):627. doi: 10.3390/life11070627. ABSTRACT The purpose of this study is to propose a ranking system for the severity of psoriasis. The consensus method of selecting the indices to include and the classification of real patient profiles by an expert panel to create a gold standard of severity were used. The performance of potential cut-offs was evaluated to create a ranking algorithm. The combined use of PASI, BSA, and sPGA may allow the classification of the severit

• Møller AH, Erntoft S, Vinding GR, Jemec GB. A systematic literature review to compare quality of life in psoriasis with other chronic diseases using …Den ganzen Artikel lesen